BioDelivery Sciences (BDSI) Tops Q1 EPS by 77c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
BioDelivery Sciences Reports First Quarter 2017 Financial Results and Provides Corporate Update
May 15, 2017 4:01 PM EDTRALEIGH, N.C., May 15, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) today reported financial results for the first quarter ended March 31, 2017 and provided a corporate update.
"We are very pleased with the financial results of the first quarter, particularly what we were able to accomplish with BELBUCA® in our hands," said Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI. "We completed a swift and effective transition of BELBUCA following the early January close of the transaction with Endo... More
